ALB Stock Cash Flow Statements

Albemarle Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Albemarle Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-09-30	2005-06-30	2005-03-31	2004-09-30	2004-06-30	2004-03-31

cash and cash equivalents at beginning of year	0	1,192,230,000	0	0	0	889,900,000	0	0	1,499,142,000	0	0	0	439,272,000	0	0	0	746,724,000	0	0	0	613,110,000	0	0	0	555,320,000	0	0	0	1,137,303,000	0	0	0	2,269,756,000	0	0	0	213,734,000	0	0	0	2,489,768,000	0	0	0	477,239,000	0	0	0	477,696,000	0	0	0	469,416,000	0	0	0	529,650,000	0	0	0	308,791,000	0	0	0	253,303,000	0	0	0	130,551,000	0	0	0	149,499,000	0	0	0	58,570,000	0	0	46,390,000	0	0	35,173,000
cash flows from operating activities:
net income	35,193,000	49,298,000	85,111,000	-1,060,641,000	-176,594,000	16,647,000	320,693,000	676,439,000	1,276,703,000	1,161,786,000	931,206,000	440,592,000	281,547,000	10,469,000	-374,433,000	446,208,000	117,698,000	102,177,000	117,045,000	103,758,000	123,635,000	106,243,000	171,618,000	174,970,000	151,526,000	146,049,000	143,479,000	310,686,000	138,925,000	-207,071,000	130,193,000	113,689,000	62,657,000	610,278,000	137,697,000	-302,754,000	235,548,000	182,677,000	70,872,000	59,366,000	47,149,000	-14,048,000	81,340,000	29,379,000	64,235,000	161,346,000	97,844,000	91,128,000	89,516,000	72,239,000	104,236,000	41,238,000	112,414,000	103,944,000	122,958,000	123,694,000	113,767,000	89,339,000	97,020,000	86,086,000	64,914,000	65,216,000	57,329,000	40,132,000	26,946,000	13,111,000	56,175,000	61,655,000	63,261,000	58,620,000	59,099,000	53,863,000	58,108,000	62,977,000	2,289,000	43,327,000	34,376,000	26,292,000	32,058,000	24,319,000	827,000	20,768,000	13,607,000
adjustments to reconcile net income to cash flows from operating activities:
depreciation and amortization	168,731,000	161,754,000	163,106,000	163,502,000	138,279,000	123,751,000	105,445,000	93,085,000	87,271,000	85,561,000	77,713,000	70,993,000	66,574,000	68,235,000	62,082,000	61,423,000	62,260,000	61,770,000	58,679,000	57,841,000	53,694,000	56,766,000	54,487,000	52,948,000	49,283,000	50,187,000	49,707,000	50,474,000	50,330,000	52,841,000	49,895,000	49,122,000	45,070,000	49,670,000	47,994,000	67,953,000	60,552,000	59,704,000	68,903,000	67,483,000	63,986,000	25,228,000	25,630,000	24,905,000	27,809,000	27,893,000	27,660,000	26,573,000	25,244,000	24,592,000	24,979,000	25,214,000	24,235,000	24,827,000	24,616,000	24,306,000	23,004,000	24,092,000	23,075,000	23,710,000	24,701,000	25,974,000	24,135,000	24,629,000	25,775,000	30,130,000	27,513,000	27,500,000	26,542,000	27,031,000	26,066,000	26,409,000	27,349,000	26,935,000	28,349,000	27,040,000	30,626,000	28,505,000	28,647,000	29,045,000	26,326,000	21,396,000	21,566,000
non-cash restructuring and asset write-offs			-62,444,000
stock-based compensation and other	10,102,000	6,966,000	7,698,000	9,004,000	6,122,000	9,317,000	9,448,000	9,477,000	10,540,000	5,825,000	9,417,000	10,987,000	4,245,000	5,452,000	6,243,000	5,865,000	2,560,000	6,973,000	6,099,000	7,264,000	2,501,000	4,511,000	5,033,000
equity in net income of unconsolidated investments	-78,258,000	-64,286,000	-18,997,000	-229,058,000	-286,878,000	-180,500,000	-470,306,000	-551,051,000	-396,188,000	-322,799,000	-258,884,000	-128,156,000	-62,436,000	-33,555,000	-27,706,000	-17,998,000	-16,511,000	-43,649,000	-26,154,000	-31,114,000	-26,604,000	-22,841,000	-33,236,000	-38,310,000	-35,181,000	-27,537,000	-22,081,000	-18,969,000	-20,677,000	-29,224,000	-19,044,000	-15,048,000	-21,171,000	-15,310,000	-15,363,000	-14,295,000	-16,566,000	-8,763,000	-6,050,000	-5,794,000	-10,392,000	-7,542,000	-8,650,000	-10,649,000	-8,901,000	-6,421,000	-5,338,000	-9,709,000	-10,261,000	-8,834,000	-7,935,000	-12,712,000	-8,586,000	-6,636,000	-9,500,000	-14,787,000	-12,831,000	-8,025,000	-9,179,000	-10,495,000	-10,276,000	-4,360,000	-5,809,000	-6,204,000	-5,949,000	-1,151,000	-6,281,000	-8,666,000	-7,028,000	-5,218,000	-6,281,000	-6,721,000	-6,361,000	-4,056,000	-4,383,000	-11,118,000	-5,476,000	-4,124,000
dividends received from unconsolidated investments and nonmarketable securities	7,430,000	60,335,000	10,575,000	77,432,000	220,170,000	50,756,000	859,786,000	531,887,000	547,552,000	450,344,000	193,931,000	117,796,000	39,168,000	35,017,000	15,954,000	22,470,000	4,950,000	26,852,000	48,325,000			8,764,000	2,691,000	57,257,000	3,034,000	24,621,000	2,749,000	4,583,000	25,462,000	27,486,000	3,446,000	5,903,000	2,551,000	8,777,000	3,460,000	31,322,000	200,000	2,763,000	11,623,000	42,478,000	3,048,000	2,834,000	25,910,000	8,859,000	3,085,000	2,743,000	5,290,000	13,040,000	559,000	3,664,000	6,475,000	12,586,000	4,183,000	4,963,000	5,668,000	10,833,000	2,221,000	4,495,000	3,106,000	3,637,000	5,176,000	4,985,000	7,108,000	1,991,000	3,961,000	4,557,000	3,429,000	4,013,000	1,295,000	5,123,000	2,276,000	2,767,000	1,851,000	8,665,000	1,245,000	3,150,000	570,000
pension and postretirement expense	1,808,000	1,696,000		1,277,000	1,256,000	1,273,000																29,874,000	586,000	477,000	578,000									33,635,000	4,521,000	2,001,000	1,389,000					111,735,000	4,029,000	1,248,000	16,669,000		1,578,000	1,570,000	1,582,000	48,715,000	9,657,000	9,046,000	10,024,000	6,610,000	6,880,000	7,208,000	6,463,000	5,019,000	5,287,000	5,292,000	5,395,000	2,479,000	2,536,000	2,297,000	2,396,000	709,000	537,000
pension and postretirement contributions	-4,738,000	-5,196,000	-6,040,000	-3,911,000	-4,604,000	-4,824,000	-3,611,000	-5,807,000	-2,825,000	-5,183,000	-3,244,000	-3,795,000	-3,890,000	-6,108,000	-3,879,000	-4,937,000	-15,329,000	-6,111,000	-3,631,000	-579,000	-6,113,000	-5,750,000	-2,950,000	-4,223,000	-3,555,000	-4,168,000	-3,979,000	-3,541,000	-3,548,000	-3,734,000	-3,319,000	-3,397,000	-2,891,000	-6,419,000	-4,125,000	-5,300,000	-4,224,000	-4,940,000	-5,700,000	-4,987,000	-5,986,000	-3,198,000	-6,001,000	-2,177,000	-2,540,000	-3,402,000	-5,646,000	-2,505,000	-1,741,000	-1,905,000	-15,093,000	-2,085,000	-2,527,000	-2,218,000	-1,804,000	-3,802,000	-51,949,000	-52,966,000	-3,611,000	-1,319,000	-22,209,000	-29,084,000	-3,275,000	-4,797,000	-2,544,000	-31,274,000	-3,129,000
realized loss on investments in marketable securities			0	0	0	33,746,000
unrealized loss on investments in marketable securities	-347,000	5,331,000																																																															942,000
deferred income taxes	-33,238,000	-5,669,000	-117,629,000	16,310,000	-245,534,000	116,447,000	-38,044,000	-158,818,000	14,098,000	15,371,000	38,492,000	11,729,000	27,747,000	424,000	-66,632,000	47,092,000	-19,384,000	-9,896,000	-1,070,000	4,200,000	4,790,000	6,668,000	4,156,000	-4,010,000	7,580,000	5,764,000	12,692,000	1,641,000	29,067,000	-46,618,000	7,881,000			-383,607,000	-10,008,000	413,920,000	816,000	-82,705,000	-12,386,000	-8,362,000	-32,845,000	-40,535,000	-8,298,000	-20,253,000	4,139,000	57,750,000	2,204,000	-1,595,000	6,506,000	-12,451,000	3,690,000	-13,064,000	7,238,000	29,000	-3,735,000	-2,821,000	21,209,000	22,708,000	5,150,000	9,327,000	9,914,000	12,105,000	-3,963,000	-2,232,000	-4,190,000	-21,986,000	-1,429,000	600,000	10,767,000	2,822,000	-28,250,000	10,366,000	5,934,000			-3,002,000	7,420,000
working capital changes	-74,770,000	-21,992,000		362,257,000	513,257,000	-52,320,000	-176,634,000	-391,337,000	-764,071,000		-116,200,000	-668,639,000	-219,397,000		448,463,000	57,127,000	-49,185,000		-10,857,000	-174,309,000	17,730,000		-66,349,000	-100,299,000	-122,939,000		-40,624,000	3,861,000	-95,050,000		-45,775,000	-289,813,000	-63,325,000		28,332,000	-118,483,000	10,467,000		59,755,000	-73,813,000	28,881,000		25,785,000	23,409,000	39,826,000		13,665,000	-40,377,000	-12,641,000				-32,728,000		-11,612,000	-46,680,000	-52,116,000		22,784,000	-2,483,000	-74,296,000		64,300,000	45,756,000	-32,777,000		-37,136,000	-15,359,000	-63,541,000			-17,857,000	-80,516,000
noncurrent liability changes and other	-39,116,000	357,146,000
net cash from operating activities	-7,203,000	545,383,000	674,000	240,548,000	362,892,000	97,954,000	628,853,000	73,707,000	720,980,000	952,247,000	895,291,000	-145,865,000	206,176,000	-146,329,000	104,733,000	227,904,000	157,949,000	337,200,000	253,797,000	52,863,000	155,054,000	373,736,000	146,350,000	144,372,000	54,916,000	169,224,000	153,084,000	102,303,000	121,554,000	229,135,000	129,299,000	-137,040,000	82,585,000	280,968,000	199,934,000	79,793,000	172,708,000	43,786,000	183,720,000	87,392,000	45,791,000	62,067,000	135,395,000	145,974,000	149,173,000	115,338,000	138,667,000	80,204,000	98,650,000	182,284,000	121,573,000	61,365,000	123,544,000	201,892,000	139,297,000	99,614,000	46,556,000
cash flows from investing activities:
capital expenditures	-119,628,000	-182,624,000	-355,728,000	-303,126,000	-447,614,000	-579,322,000	-545,898,000	-503,687,000	-415,608,000	-445,712,000	-313,327,000	-270,909,000	-231,698,000	-300,928,000	-255,824,000	-217,232,000	-179,683,000	-229,106,000	-202,380,000	-204,462,000	-214,529,000	-243,340,000	-192,830,000	-199,494,000	-216,132,000	-228,316,000	-190,730,000	-149,130,000	-131,815,000	-130,184,000	-89,754,000	-43,622,000	-54,143,000	-55,353,000	-41,792,000	-41,389,000	-58,120,000	-63,081,000	-52,845,000	-54,982,000	-56,741,000	-33,894,000	-30,012,000	-23,003,000	-23,667,000	-20,318,000	-31,860,000	-47,833,000	-55,335,000	-62,165,000	-92,085,000	-71,839,000	-54,784,000	-63,463,000	-59,484,000	-35,733,000	-31,894,000	-25,472,000	-16,076,000	-17,789,000	-16,141,000	-17,176,000	-23,151,000	-27,391,000	-33,068,000	-36,269,000	-23,230,000	-20,098,000	-20,139,000	-27,478,000	-21,281,000	-23,740,000	-26,241,000	-26,744,000	-24,091,000	-27,994,000	-21,018,000	-14,405,000	-17,388,000	-18,801,000	-17,968,000	-11,236,000	-8,398,000
free cash flows	-126,831,000	362,759,000	-355,054,000	-62,578,000	-84,722,000	-481,368,000	82,955,000	-429,980,000	305,372,000	506,535,000	581,964,000	-416,774,000	-25,522,000	-447,257,000	-151,091,000	10,672,000	-21,734,000	108,094,000	51,417,000	-151,599,000	-59,475,000	130,396,000	-46,480,000	-55,122,000	-161,216,000	-59,092,000	-37,646,000	-46,827,000	-10,261,000	98,951,000	39,545,000	-180,662,000	28,442,000	225,615,000	158,142,000	38,404,000	114,588,000	-19,295,000	130,875,000	32,410,000	-10,950,000	28,173,000	105,383,000	122,971,000	125,506,000	95,020,000	106,807,000	32,371,000	43,315,000	120,119,000	29,488,000	-10,474,000	68,760,000	138,429,000	79,813,000	63,881,000	14,662,000
proceeds from sale of property and equipment																						0	0	0	10,356,000
proceeds from sale of available for sale debt securities
proceeds from settlement of foreign currency forward contracts
sales of marketable securities	-410,000	3,381,000								-1,190,000	-270,000	-349,000	3,751,000	-633,000	-146,000	-692,000	5,245,000		-288,000	-1,093,000	2,589,000			-182,000	1,090,000			-449,000	10,000		242,000	-284,000	492,000	-517,000	-147,000	-222,000	1,191,000	-267,000	-168,000	-124,000	1,557,000		301,000	-1,509,000	2,151,000										-178,000	-65,000	1,872,000
investments in equity investments and nonmarketable securities	-60,000	-60,000	-53,000	-69,000	-74,000	-74,000
net cash from investing activities	362,915,000	-179,303,000	-327,810,000	-302,122,000	-450,003,000	-494,503,000	-662,925,000	-513,698,000	-539,008,000	-609,340,000	-313,337,000	-271,879,000	-228,093,000	-307,763,000	-256,646,000	72,543,000	-174,724,000	-220,052,000	-202,968,000	-205,685,000	-234,868,000	-1,064,133,000	-192,581,000	-199,716,000	-207,195,000	-227,989,000	-201,411,000	258,245,000	-132,540,000	-133,435,000	-95,393,000	-48,832,000	-80,143,000	2,832,356,000	-41,939,000	-38,177,000	168,248,000	-60,598,000	51,120,000	-58,401,000	-2,092,673,000	-67,613,000	67,508,000	-24,512,000	-21,516,000	-23,678,000	-31,414,000	-48,136,000	-54,514,000	-56,328,000	-104,591,000	-84,211,000	-56,031,000	-65,541,000	-64,799,000	-41,275,000	-41,321,000	-31,596,000	-14,707,000	-17,967,000	-27,921,000	-19,234,000	-28,387,000	-36,293,000	-37,716,000	-44,455,000	-59,842,000	-40,474,000	-18,933,000	-34,391,000	-45,055,000	-24,842,000	-28,642,000			-28,270,000	-23,810,000	-8,857,000	-22,479,000	-28,797,000	-797,692,000	-8,155,000	-13,723,000
cash flows from financing activities:
proceeds from issuance of mandatory convertible preferred stock, net of issuance costs			0	0	0	2,236,750,000
repayments of long-term debt and credit agreements	-19,488,000	-9,615,000	-28,036,000	-27,950,000	-27,434,000	-29,019,000				-250,000,000	0			0	0	1,157,000	-1,174,980,000
proceeds from borrowings of long-term debt and credit agreements			28,036,000	27,950,000	27,434,000	29,019,000	0				0
other debt repayments	-1,232,000	-1,195,000			-6,637,000	-620,753,000		-787,000	-713,000		-466,000	-223,986,000	-166,615,000			-157,000	-325,159,000
dividends paid to common shareholders	-47,637,000	-47,607,000	-47,601,000	-47,013,000	-47,008,000	-46,908,000
dividends paid to mandatory convertible preferred shareholders	-41,687,000	-41,688,000	-41,687,000	-41,683,000
dividends paid to noncontrolling interests	0	-18,169,000	-18,000	-19,039,000			-26,248,000	0	-53,145,000	0	-17,683,000			-34,958,000	-17,480,000	-17,479,000	-26,219,000	-17,775,000	0	0	-14,286,000	-25,975,000	-18,250,000			0	-7,378,000	0	-7,378,000	-8,965,000	-9,861,000			-11,982,000	-6,821,000			-91,000	-14,913,000			-7,923,000				0				0	0											-2,798,000	0	-6,000,000	-2,911,000
proceeds from exercise of stock options	0	1,186,000	260,000	28,000	0	86,000	36,000	0	81,000	1,193,000	735,000	436,000	419,000	2,172,000	1,885,000	13,152,000	1,183,000	23,512,000	6,116,000	614,000	10,195,000	0	1,609,000	529,000	2,676,000	1,331,000	1,014,000	642,000	646,000	1,227,000	3,674,000	1,167,000	2,170,000	2,622,000	1,840,000			175,000	0	252,000	90,000	0	358,000	1,100,000	1,255,000	1,043,000	593,000	2,197,000	1,720,000	1,171,000	6,547,000	10,861,000	2,569,000	1,127,000	21,000	877,000	205,000	2,456,000	2,908,000	793,000	978,000	70,000	1,876,000	1,544,000	663,000	0	0	533,000	3,398,000	1,490,000	4,504,000	5,003,000	10,952,000	7,701,000	838,000	1,901,000	10,955,000	189,000	409,000	2,295,000	1,976,000	1,287,000	3,499,000
withholding taxes paid on stock-based compensation award distributions	-37,000	-2,904,000	-999,000	-215,000	-58,000	-10,619,000	-1,256,000	-6,293,000	-18,617,000	-1,188,000	-1,567,000	-161,000	-10,422,000	-385,000	-708,000	-187,000	-6,860,000	-340,000	-784,000	-194,000	-3,825,000	-257,000	-204,000	-315,000	-10,255,000	-193,000	-587,000	-1,451,000	-15,009,000	-59,000	-148,000	-314,000	-7,855,000	-186,000	-26,000	-13,000	-1,969,000	-331,000	0	-44,000	-1,174,000	-76,000	-58,000	-182,000	-2,968,000	-51,000	-321,000	-334,000	-5,443,000	0	-126,000	-2,482,000	-6,516,000	-804,000	-553,000	-1,221,000	-551,000	-83,000	-796,000	-3,035,000	-74,000	-225,000	-39,000	-221,000	-4,577,000	-305,000	-949,000	-1,000	-10,156,000	0	-413,000	0	-3,406,000
other	-41,000	-14,000	-89,689,000	101,296,000	-95,635,000	-23,076,000	-10,119,000	-120,403,000	-15,987,000	5,635,000	6,428,000	-45,374,000	1,899,000	47,432,000	9,428,000	-9,196,000	5,857,000	75,973,000	69,123,000	75,062,000	-12,233,000	13,864,000	11,438,000	1,083,000	10,589,000	-31,466,000	9,337,000	-31,799,000	-4,541,000	438,823,000	-1,109,000	3,286,000	8,816,000	50,648,000	6,943,000	3,079,000	799,000	-13,321,000	716,000	6,498,000	-51,019,000	15,923,000	-12,391,000	3,541,000	-330,000	3,333,000	-526,000	1,556,000	311,000	14,399,000	-4,712,000	-954,000	8,171,000	-3,658,000	-1,172,000	-2,657,000	-4,700,000	-3,430,000	-2,625,000	-1,076,000	2,613,000	1,097,000	7,267,000	10,390,000	-2,032,000	-614,000	9,437,000	391,000	-5,608,000	-4,052,000	5,878,000	-2,681,000	-2,868,000	6,474,000	1,842,000	2,311,000	39,000	911,000	-244,000	1,562,000	9,314,000	-8,767,000	-835,000
net cash from financing activities	-90,634,000	-120,006,000	-92,881,000	-109,966,000	-112,718,000	1,557,300,000	99,698,000	245,885,000	-118,676,000	-299,364,000	-65,278,000	918,910,000	57,619,000	308,649,000	-63,903,000	-51,285,000	-143,249,000	-101,937,000	-95,847,000	324,029,000	51,016,000	987,442,000	-6,722,000	-13,290,000	75,257,000	-13,598,000	-216,061,000	-118,585,000	-438,282,000	-8,601,000	3,539,000	-60,007,000	-1,021,799,000	-1,067,663,000	-115,405,000	-97,559,000	-297,276,000	-10,328,000	-201,665,000	-83,685,000	-182,647,000	1,859,078,000	-40,934,000	-128,201,000	-80,614,000	-19,008,000	-25,085,000	-159,921,000	-84,032,000	-53,943,000	-76,621,000	-24,600,000	-22,130,000	-137,646,000	-77,869,000	-10,341,000	-103,263,000	89,570,000	-37,928,000	-33,138,000	-26,442,000			-85,869,000	-26,677,000				-1,464,000	-34,310,000			-3,673,000									-46,088,000	-15,195,000
net effect of foreign exchange on cash and cash equivalents	23,240,000	80,207,000	-52,272,000	5,832,000	-25,757,000	5,162,000	-63,696,000	207,110,000	24,296,000	72,796,000	-64,469,000	-33,895,000	-11,649,000	-10,334,000	-12,707,000	4,551,000	-16,841,000	29,440,000	10,395,000	12,261,000	-31,084,000	-1,758,000	-27,407,000	1,543,000	-13,024,000	-13,543,000	-2,530,000	-26,007,000	4,153,000	4,865,000	949,000	-1,712,000	4,137,000	-9,504,000	-2,652,000	-2,778,000	-5,032,000	6,384,000	-5,923,000	511,000	1,182,000	-16,884,000	-23,968,000	-2,185,000	-239,000	3,160,000	4,600,000	7,608,000	-2,896,000	3,041,000	530,000	-10,162,000	4,560,000	-10,547,000	-6,086,000	1,704,000	9,391,000	-8,574,000	11,597,000	-8,149,000	-5,195,000	-4,739,000	702,000	4,325,000	-912,000	-14,475,000	-7,067,000	-1,126,000	6,998,000	4,269,000	-69,000	5,028,000	1,882,000	533,000	-2,845,000	4,371,000	1,221,000	1,925,000	-9,577,000	-6,625,000	2,975,000	1,657,000	-459,000
increase in cash and cash equivalents	288,318,000	326,281,000	-472,289,000	-165,708,000	-225,586,000	1,165,913,000	1,930,000	13,004,000	87,592,000	116,339,000	452,207,000	467,271,000	24,053,000	-155,777,000	-228,523,000			44,651,000	-34,623,000											91,964,000			-1,015,220,000	2,036,157,000			38,648,000	-20,756,000	27,252,000	-54,183,000	-2,228,347,000	1,836,648,000	138,001,000	-8,924,000	46,804,000				-42,792,000				49,943,000	-11,842,000	-9,457,000			104,977,000	100,550,000			48,357,000	87,958,000	-11,423,000	-69,404,000	46,092,000	38,729,000	33,352,000	4,579,000	29,270,000	-99,125,000	75,390,000	-24,483,000	59,924,000	-9,420,000	31,895,000	8,530,000	-50,429,000	24,508,000	27,390,000	22,164,000	-11,868,000	15,348,000
cash and cash equivalents at end of period	288,318,000	1,518,511,000		-165,708,000	-225,586,000	2,055,813,000	1,930,000	13,004,000	1,586,734,000		452,207,000	467,271,000	463,325,000		-228,523,000	253,713,000	569,859,000		-34,623,000	183,468,000	553,228,000		-80,360,000	-67,091,000	465,274,000		-266,918,000	215,956,000	692,188,000		38,394,000	-247,591,000	1,254,536,000		39,938,000	-58,721,000	252,382,000		27,252,000	-54,183,000	261,421,000		138,001,000	-8,924,000	524,043,000		86,768,000	-120,245,000	434,904,000		-59,109,000	-57,608,000	519,359,000		-9,457,000	49,702,000	441,013,000		100,550,000	56,806,000	267,317,000		87,958,000	-11,423,000	183,899,000		38,729,000	33,352,000	135,130,000		-99,125,000	75,390,000	125,016,000		-9,420,000	31,895,000	67,100,000	-50,429,000	24,508,000	73,780,000	22,164,000	-11,868,000	50,521,000
(gain) loss on change in interest in properties/sale of business
inventory net realizable value adjustment
pension and postretirement benefit							1,992,000	1,979,000	1,954,000		-4,026,000	-4,023,000	-4,250,000		-3,986,000	-4,239,000	-4,226,000											-903,000	-890,000
loss on early extinguishment of debt										0	0			0	0	1,157,000	27,798,000													0	0	0	52,801,000
changes in current assets and liabilities, net of effects of acquisitions and divestitures:
decrease (increase) in accounts receivable
decrease (increase) in inventories
decrease (increase) in other current assets
increase in accounts payable to third parties
increase in accounts payable to related parties
increase in accrued expenses and income taxes payable
acquisitions, net of cash acquired							-34,967,000											0	0	0	-22,572,000					0	-3,760,000				-5,881,000	-11,783,000	-27,742,000
sales (purchases) of marketable securities			-1,131,000	1,073,000	-2,315,000	84,893,000
other (repayments) borrowings																					-151,872,000					20,938,000	77,328,000	169,326,000	-381,159,000													17,729,000	-10,471,000
fees related to early extinguishment of debt										0	0			0	0	-1,158,000	-23,719,000													0	0	0	-46,959,000
cash and cash equivalents at end of year
albemarle corporation and subsidiaries
notes to the consolidated financial statements
unrealized gain on investments in marketable securities				3,205,000	17,040,000	6,737,000				-585,000	803,000	1,592,000	1,469,000	94,000	-1,528,000	-622,000	-1,762,000	-1,258,000	-2,099,000	-651,000	-627,000	-1,108,000	-1,124,000	-101,000	-476,000	1,088,000	-990,000	-232,000	-393,000	-1,128,000	-454,000			-374,000	-3,271,000	-1,054,000	1,044,000	-642,000	-26,000	-109,000	-462,000	-300,000	178,000	-68,000	-635,000	-1,757,000	-12,000	-875,000	-1,037,000	-460,000	-942,000	792,000	-1,262,000	-52,000	1,274,000	-427,000	-1,483,000		139,000
other debt (repayments) borrowings
non-cash capital project assets write-off
loss on sale of investment in properties													8,400,000
unrealized (gain) loss on investments in marketable securities							24,694,000	-15,702,000	-45,732,000																								-873,000																												-368,000	-902,000
non-cash transfer of 40% value of construction in progress of kemerton plant to mrl							5,509,000	3,958,000	7,665,000	6,713,000	19,655,000	31,214,000	65,100,000	0	39,743,000	52,962,000	43,223,000
(purchases) sales of marketable securities							-81,973,000	-1,712,000	-122,267,000
other debt borrowings (repayments)
dividends paid to shareholders							-46,934,000	-47,035,000	-46,282,000	-46,264,000	-46,271,000	-46,257,000	-45,637,000	-45,617,000	-45,599,000	-45,507,000	-41,130,000	-40,982,000	-40,927,000	-40,927,000	-38,982,000	-38,883,000	-39,008,000	-38,926,000	-35,387,000	-35,674,000	-36,438,000	-37,102,000	-35,382,000	-35,352,000	-35,443,000	-35,432,000	-34,330,000	-34,292,000	-34,270,000	-34,250,000	-32,541,000	-32,532,000	-32,532,000	-32,508,000	-21,730,000	-21,275,000	-21,511,000	-21,734,000	-19,582,000	-19,533,000	-19,525,000	-21,241,000	-17,808,000	-17,826,000	-17,888,000	-17,821,000	-15,578,000	-14,661,000	-15,138,000	-15,104,000	-12,856,000	-12,760,000	-12,754,000	-12,728,000	-11,401,000	-11,126,000	-11,358,000	-10,987,000	-10,961,000	-10,927,000	-10,918,000	-10,769,000	-9,707,000	-9,859,000	-9,985,000	-11,559,000	-8,628,000	-8,496,000	-7,838,000	-7,776,000	-7,472,000	-7,014,000	-6,980,000	-4,998,000	-6,108,000	-5,911,000	-5,963,000
investments in equity and other corporate investments								-59,000	-1,133,000	-199,000	260,000	-621,000	-146,000	-6,202,000	0	0	-286,000	-1,641,000	-300,000	-130,000	-356,000	0	-20,000	-40,000	-2,509,000	-254,000	-3,367,000	-1,244,000	-735,000																									0	0	-202,000	-10,666,000
gain on sale of business/interest in properties
pension and postretirement (benefit) expense																			-1,663,000	-1,593,000	-1,719,000											19,000	-26,000					-38,585,000	839,000	387,000	-1,458,000
increase in accounts receivable
increase in inventories
increase in other current assets
increase in accounts payable
cash proceeds from divestitures														0	-676,000											90,000	-3,232,000			0	0			3,014,972,000	0	3,434,000	307,165,000	2,750,000				0																0
proceeds from sale of joint venture
proceeds from issuance of common stock														0	0	0	1,453,888,000																																																													0	0	147,862,000
proceeds from borrowings of other long-term debt
gain on sale of business/investment in properties											0
proceeds from borrowings of credit agreements													280,000,000						0	202,163,000	250,000,000
gain on sale of property																						-3,332,000	0	0	-11,079,000
other borrowings (repayments)																							49,131,000	64,829,000	118,223,000					59,548,000										-33,872,000	167,571,000				-8,434,000	41,165,000
gain on sale of business															984,000												0
decrease in cash and cash equivalents																	-176,865,000				-59,882,000		-80,360,000	-67,091,000	-90,046,000		-266,918,000	215,956,000	-445,115,000																		86,768,000				-59,109,000						-88,637,000				-41,474,000
gain on sale of business or joint venture
(decrease) in accrued expenses and income taxes payable
sales of (investments in) marketable securities																						-793,000																								-1,045,000	446,000	-53,000	821,000									-286,000	-275,000	-173,000	1,386,000
repayments of long-term debt																														-25,000,000	-2,000,000	0	-751,209,000	-869,572,000	-568,000	-50,567,000	-331,595,000	-1,293,948,000	-645,000	-5,385,000	-1,326,263,000	-2,994,000	-7,000	-2,915,000	-101,000	-41,820,000	-87,533,000	-2,776,000	-3,604,000	-14,568,000	-39,860,000	-2,234,000	-7,149,000	-4,515,000	130,000	-4,584,000	-100,622,000	-314,777,000	-80,822,000	-14,079,000	-14,445,000	-1,000,000	-15,570,000	-81,928,000	-35,834,000	-5,571,000	7,661,000	-4,993,000	-45,273,000	-4,260,000	-114,012,000	-2,793,000	-12,441,000	-55,076,000	-19,180,000	-118,062,000	-46,939,000	-118,478,000	-28,427,000	-470,992,000	-259,332,000	-47,105,000	-19,369,000
repurchases of common stock																										0	-250,000,000			0	0	0	-250,000,000									0	0	-100,000,000	-50,000,000	0	0	-521,500,000	-60,798,000	-23,105,000	-26,775,000			0				0
debt financing costs																		-1,201,000	-82,000	-2,455,000	-214,000																	-358,000	-3,022,000	0	-1,164,000	-14,570,000	-1,702,000	-2,000	-1,370,000	0	25,000							0																0	-5,000
repayments of borrowings from credit agreements
other borrowings																			189,830,000													-7,498,000	66,384,000			-964,000	68,829,000
gain on acquisition																														-196,000	1,408,000	0	-7,433,000
(increase) in accounts receivable
(increase) in inventories
(increase) in other current assets
repayments from joint ventures																														0	0	0	1,250,000
stock-based compensation																									5,556,000	3,443,000	3,709,000	5,207,000	2,869,000	3,809,000	6,103,000	4,446,000	5,046,000	3,213,000	5,085,000	4,726,000	4,007,000	4,017,000	1,978,000	4,281,000	4,912,000	3,820,000	3,128,000	3,917,000	3,402,000	3,128,000	2,507,000	2,016,000	2,513,000	4,403,000	78,000	3,804,000	6,926,000	7,704,000	5,473,000	7,103,000	6,789,000	4,229,000	2,873,000	4,245,000	4,347,000	2,185,000	2,401,000	2,130,000	-6,409,000
gain on sales of businesses																																			0	-974,000	-121,324,000
cash payments related to acquisitions and other																																		1,000	0	0	-81,988,000									-2,315,000	0			-872,000	-104,000	-2,250,000	-134,000	-2,119,000	-5,137,000	-5,275,000	-633,000
(investments in) sales of marketable securities																										491,000																								-478,000	98,000	-122,000	-1,113,000
proceeds from borrowings of long-term debt																																							0	0	1,000,000,000					0	0
gain associated with restructuring and other
acquisition of rockwood, net of cash acquired																																						0	0	0	-2,051,645,000
other acquisitions, net of cash acquired																																						0	0
decrease in restricted cash																																						0	0	0	57,550,000
return of capital from unconsolidated investment
purchase of noncontrolling interest
deferred income tax expense																																	1,363,000
(gain) loss associated with restructuring and other																																						0
(gain) loss on sales of businesses
excess tax benefits realized from stock-based compensation arrangements																																		-442,000	-1,331,000			-62,000	0	-36,000	-23,000	10,000	-69,000	-181,000	-586,000	-188,000	-559,000	-618,000	-1,901,000	-385,000	-2,095,000	-7,785,000	-4,544,000	-4,651,000	-229,000	-1,827,000	-3,867,000	-3,799,000	-3,136,000	-566,000	-480,000	-73,000	-918,000	-894,000	-226,000	7,316,000	0	-768,000	-6,920,000	-188,000
decrease in other current assets excluding deferred income taxes
payment for settlement of interest rate swap
repayments from (long-term advances to) joint ventures																																						0
proceeds from issuance of senior notes																																																																														0	0	324,665,000
repayments of other borrowings
loss on disposal of businesses																																										0
return of capital
write-offs associated with restructuring and other																																										0	0	3,333,000	3,000,000
impairment of assets of discontinued operations
proceeds from repayment of advance to joint venture																																								0	2,156,000
acquisition of remaining interest in shanghai chemetall, net of cash acquired																																									-45,550,000
decrease (increase) in other current assets excluding deferred income taxes
long-term advances to joint ventures
long-term advances to joint venture																																																			-12,500,000
change in current assets and liabilities:
non-cash charges associated with restructuring and other
proceeds from other borrowings
increase in other current assets excluding deferred income taxes
cash impact from deconsolidation of stannica llc																																																										425,000
december 31, 2012
accumulated other comprehensive income
retained earnings
restructuring and other charges																																																			6,508,000							0	0	0	6,958,000
proceeds from borrowings																																																							118,301,000	7,864,000	6,694,000		50,400,000	1,656,000	6,654,000	-5,969,000	-12,479,000	10,608,000	22,140,000	-30,057,000	70,691,000	14,684,000	199,928,000	29,824,000	3,256,000	57,045,000	17,824,000	477,000	3,101,000	87,035,000	43,674,000	30,267,000	48,839,000	68,533,000	1,036,171,000	6,810,000	7,965,000
working capital changes, net of effects of restructuring and other charges
port de bouc charges																																																														0	0
net change in noncurrent income tax payables and receivables																																																								-177,000	-684,000	-58,000	-55,000	132,000	2,222,000	-17,651,000	2,062,000	-16,067,000	-2,364,000
net change in noncurrent environmental liabilities																																																								-352,000	733,000	2,691,000	760,000	-570,000	-527,000	-1,349,000	320,000	-493,000	-3,051,000	-2,095,000	-1,365,000	-1,706,000	413,000	-2,121,000	-395,000
change in current assets and liabilities, net of effects of acquisitions and special items:
cash payments related to the port de bouc facility divestiture																																																														0	-5,192,000	-6,899,000	-4,349,000
•
adjustments to reconcile income to cash flows from operating activities:
increase in accrued expenses and income taxes
cash payments related to the thann facility divestiture
collection of note receivable from sale of land																																																																		0	0	0	6,000,000
net cash provided from operating activities																																																											141,588,000	116,060,000	18,084,000	99,117,000	157,093,000			166,121,000	55,068,000	76,580,000	17,978,000	93,702,000	67,527,000	75,363,000	5,950,000	160,436,000	84,049,000			52,739,000			45,774,000	40,718,000	44,725,000
cash payments related to asset and business acquisitions
investments in other corporate investments																																																											0			0	0				0				0	0	-84,000				-64,000
cash impact from deconsolidation of stannica jv																																																												0	-13,074,000
cash payments related to acquisitions																																																												0	-92,000	-1,939,000	-285,000
purchases of common stock																																																												-6,311,000	-8,634,000					-5,450,000	-12,365,000	0	-151,137,000	-49,253,000	-4,261,000	-29,048,000	-18,647,000	-17,143,000	-4,809,000	-905,000	-8,980,000				0	0	-827,000
dayton facility closure charge																																																																						0	0
postretirement plan elimination gain																																																																						0	0	0	-2,107,000
change in current assets and liabilities, net of effects of acquisitions and facility disposition charges:
investments in marketable securities																																																														-119,000	241,000	-170,000	-299,000	-1,368,000	706,000	-362,000	-2,238,000	-835,000	-230,000	-1,102,000	-2,731,000	-970,000	-442,000	-172,000	-2,728,000
proceeds from sale of marketable securities, liquidation and sale of unconsolidated investments and sale of nonmarketable security
restructuring charges
net cash (used in) provided from financing activities																																																																												-39,288,000	-5,608,000
net cash (used in) provided from operating activities																																																																	-4,099,000															-2,443,000
cash transferred and payments related to the thann facility divestiture																																																																		0	0	0	-2,556,000	-5,552,000				-780,000
loss on thann facility divestiture																																																																										0
port de bouc facility disposition charge
stock-based compensation expense																																																																		4,682,000	3,679,000	5,516,000	4,590,000	4,655,000	4,760,000	4,556,000	4,139,000	4,321,000
minority interests in income of consolidated subsidiaries																																																																		5,238,000	4,587,000	5,396,000	3,585,000	5,322,000	4,613,000	2,746,000	4,951,000	4,463,000	5,176,000	394,000	3,225,000
change in assets and liabilities, net of effects of acquisitions and facility disposition charges:
acquisitions, net of 307 and 3,880 cash acquired in 2008 and 2007, respectively																																																																		-6,677,000
investments in unconsolidated investments and other corporate investments
dividends paid to minority interests																																																																		-1,778,000	-4,499,000	-1,851,000	-5,486,000	-2,440,000	-4,340,000	-3,174,000	-4,374,000
severance charges																																																																			0	0	3,278,000
proceeds from sale of marketable securities																																																																							0	0	414,000
net cash provided from (used in) financing activities																																																																															12,841,000	65,255,000
acquisitions																																																																														0	2,724,000	-10,277,000
net change in pension and postretirement assets and liabilities																																																																					-2,500,000
benefit plan curtailment gains
change in assets and liabilities, net of effects of acquisitions, the thann facility divestiture and the consolidation of jordan bromine company limited:
increase in prepaid expenses
acquisitions, net of 3,880 cash acquired in 2007																																																																						-485,000
net receipt on treasury lock agreements
working capital changes, net of the effects of acquisitions and the thann facility divestiture
net change in pension assets and liabilities																																																																							1,791,000
tax benefit realized from stock-based compensation arrangements																																																																								4,536,000	12,620,000	4,747,000	744,000	919,000	4,354,000
increase in prepaid pension assets																																																																									-1,124,000								-1,594,000	-1,693,000	-636,000
payment of financing costs																																																																									-979,000					0	0	-2,306,000
loss on hedging of anticipated acquisition purchase price
purchased in-process r&d charges
benefit plan curtailment (gains) charges
insurance receivable valuation adjustment
decrease (increase) in prepaid pension assets																																																																														647,000	516,000	614,000
acquisitions, net of cash acquired in 2004
investments in unconsolidated investments and nonmarketable securities																																																																										-96,000
payments on hedging of anticipated acquisition purchase price
proceeds from liquidation and sale of unconsolidated investments and sale of nonmarketable security
net receipt (payments) on treasury lock agreements
working capital changes, net of the effects of acquisitions, the thann facility divestiture and the consolidation of jordan bromine company limited
decrease in prepaid pension assets																																																																											1,566,000	1,757,000	1,381,000
deferred income tax
proceeds from liquidation of unconsolidated investment and sale of nonmarketable security
net cash (used in) investing activities
dividends paid to minority interest																																																																											0	-2,400,000	-1,200,000	-1,200,000			-1,600,000	-1,169,000	-500,000
net cash (used in) financing activities
stock based compensation expense																																																																												4,622,000	2,491,000
working capital changes, net of the effects of acquisitions																																																																												26,601,000	-37,925,000		-8,781,000	-53,120,000	-4,947,000	9,014,000	11,023,000
investments in and advances to unconsolidated investments and nonmarketable securities
net cash provided from (used in) operating activities																																																																													36,727,000
compensation payable in common stock and options																																																																														821,000	2,594,000	2,529,000
working capital changes, net of the effects of acquisitions and the consolidation of jordan bromine company limited
deferred income tax (benefit) expense
investments in joint ventures and other investments
proceeds from the liquidation of equity method investment and sale of nonmarketable security																																																																														0
investments in and advances to joint ventures and nonmarketable securities
proceeds from hedging of anticipated acquisition purchase price
equity in (net income) losses of unconsolidated investments																																																																																-7,392,000
investments in joint ventures and nonmarketable securities																																																																																-391,000	-1,712,000	-305,000	-4,725,000
cumulative effect of a change in accounting principle
income before cumulative effect of a change in accounting principle																																																																																	827,000	20,768,000	13,607,000
adjustments to reconcile net income before cumulative effect of a change in accounting principle, net to cash flows from operating activities:
purchased in-process r & d charges
increase in income tax receivable
acquisitions of assets/business, net of 34,418 cash acquired
proceeds from liquidation of nonmarketable security
net cash provided from financing activities
(a) supplemental noncash disclosures due to a cumulative change in accounting principle:
increase in property, plant and equipment
increase in accumulated depreciation
increase in other noncurrent liabilities
decrease in deferred tax liabilities
acquisitions of assets																																																																																		397,000	-600,000

We provide you with 20 years of cash flow statements for Albemarle stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Albemarle stock. Explore the full financial landscape of Albemarle stock with our expertly curated income statements.

The information provided in this report about Albemarle stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.